Latest news articles

Added 3 days ago Drug news

Phase II data annonuced for once-daily, fixed dose combination asthma treatment

Novartis announced that new phase II data for IND/GLY/MF (QVM 149), an investigational, once-daily, fixed dose combination asthma treatment containing...

Added 3 days ago Drug news

AstraZeneca reports data from Novel START trial of Symbicort Turbuhaler to relieve inflammation in mild asthma

New data from Novel START, an open-label trial designed to reflect real-world practice , has demonstrated the effectiveness of Symbicort...

Added 6 days ago Drug news

Allergenic Products Advisory Committee to review AR 101 to treatpeanut allergy

Aimmune Therapeutics, Inc.a biopharmaceutical company developing treatments for life-threatening food allergies, announced that it has been informed by the FDA...

Search all news articles for Allergy/clinical immunology
 

 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

EADV 2018 Highlights

EADV 2018 Highlights

EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Transplantation

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Load more

 

Guidelines

Asthma: diagnosis, monitoring and chronic asthma management

This guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce the risk of asthma attacks.

Added 11 months ago

BSACI guidelines for the management of allergic and non-allergic rhinitis

This is an updated guideline for the diagnosis and management of allergic and non-allergic rhinitis, first published in 2007.

Added 11 years ago

British Guideline on the Management of Asthma

The 2016 update includes a complete revision of the section on diagnosis of asthma and a major update to the section on pharmacological management of asthma as well as revisions to the sections on supported self management...

Added 4 years ago

Search all guidelines for Allergy/clinical immunology
 

Journal articles

Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide.

Background: Atopic dermatitis (AD) is a heterogeneous disease with a multifactorial aetiology and complex pathophysiology. This heterogeneity translates into different trajectories of disease progression with respect to...

Added 1 month ago

Epigenetic changes: An emerging potential pharmacological target in allergic rhinitis.

The importance of epigenetics has increased due to identification of its role in the pathophysiology of a number of diseases including allergic rhinitis. Amongst the different epigenetic changes in allergic retinitis, deacetylation...

Added 1 month ago

Increased salivary fluid flow in children with newly diagnosed allergic rhinitis.

Objectives: The pathogenesis of allergic rhinitis (AR) may involve dysregulation of the autonomic nervous system (ANS). Salivary fluid flow and salivary alpha-amylase (sAA) secretion are able to reflect the activity of...

Added 1 month ago

Search all journal articles for Allergy/clinical immunology
 

Clinical trials

Mepolizumab for the Treatment of Chronic Spontaneous Urticaria

This is an exploratory study designed to generate preliminary data in evaluating the efficacy of Nucala in the treatment of chronic spontaneous urticaria.

Added 2 months ago

A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis (Heads Up)

This is a phase 3, randomized, multi-center study that will evaluate upadacitinib versus dupilumab in adults (18-75 years of age) with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.

Added 2 months ago

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis (JADE TEEN)

This is a randomized, double blind, placebo controlled, parallel group, Phase 3 study to evaluate the efficacy and safety of PF 04965842 in adolescent participants 12 to <18 years of age with moderate to severe AD

Added 2 months ago

Search all clinical trials for Allergy/clinical immunology
 

Blog Posts

The Asthma Report

ERS 2018 | Day 4 Highlights

Posted 8 months ago

A look at two sessions from the ERS Congress dealing with devices for the management of asthma and an in-depth look at some of the allergic responses to asthma.

Lauren McCracken

EAACI hot topics: Hereditary angioedema (HAE)

Posted 10 months ago

For many the fear of the unknown is a daunting thought, but particularly so for patients with HAE. Left untreated, this disease causes unpredictable recurrent severe swelling, typically of the limbs, face, intestinal tract and airway.

Alex Keen

EULAR 2018 – Biosimilars: the future of rheumatology?

Posted 11 months ago

EULAR's Annual European Congress of Rheumatology aims to encourage innovation and collaboration across all aspects of rheumatology, something that is particularly well illustrated by biologics and their more affordable counterpart, biosimilars. Could they unlock the door to accessible, life-changing treatment for millions more?

CME

EAACI 2017: The future of urticaria – advances in CSU research

EAACI 2017: The future of urticaria – advances in CSU research
Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
FREE

Chronic Spontaneous Urticaria Case Consults: Changing Paradigms in the Age of Biologics

Chronic Spontaneous Urticaria Case Consults: Changing Paradigms in the Age of Biologics
Accrediting body
Credits available
0
Registration required
1
Subscription fee
FREE

Managing CSU and its comorbidities: from primary to secondary care

Managing CSU and its comorbidities: from primary to secondary care
Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
FREE
Search all CME for Allergy/clinical immunology